EnWave Cuts Losses, Boosts Royalties on Machine Sales and Partner Growth
Event summary
- Q3 2026 revenue rose 21% YoY to $3.3M CAD, driven by a large-scale machine sale and higher royalties.
- Base royalties increased 24% YoY to $536K CAD due to higher product sales and partner production.
- Gross margin improved to 25% from 19% YoY, attributed to lower fabrication costs.
- Adjusted EBITDA loss narrowed by $482K YoY to $93K CAD, reflecting lower SG&A expenses.
- Nine-month revenue declined 20% YoY to $6.07M CAD, primarily due to fewer machine sales.
The big picture
EnWave's Q3 2026 results highlight the tension between cyclical machine sales and recurring royalty income. The company's strategic focus on licensing its REV technology to global food and cannabis partners is paying off in margin expansion, but revenue volatility remains a challenge. The food processing industry's shift toward efficient dehydration solutions positions EnWave as a key player, though its ability to convert evaluations into long-term licenses will determine its trajectory.
What we're watching
- Royalty Sustainability
- Whether EnWave can maintain royalty growth as partner production scales.
- Machine Sales Volatility
- The impact of lumpy large-scale machine sales on quarterly revenue stability.
- Operational Efficiency
- How further SG&A reductions will affect R&D and commercial expansion.
Related topics